Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes treating to target with basal insulin

被引：0
|
作者：
Riddle, Matthew
Zhang, Bei
Maier, Holly
Wilhelm, Ken
Kolterman, Orville
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A156 / A156
页数：1
相关论文
共 50 条
  • [21] Amylin replacement with pramlintide as an adjunct to insulin therapy facilitates a combined improvement in glycemic and weight control in type 2 diabetes.
    Maggs, DG
    Weyer, C
    Burrell, T
    Gottlieb, AD
    Shen, LZ
    Kolterman, OG
    [J]. DIABETOLOGIA, 2001, 44 : A237 - A237
  • [22] Amylin replacement with pramlintide as an adjunct to insulin therapy facilitates a combined improvement in glycemic and weight control in type 2 diabetes.
    Maggs, DG
    Weyer, C
    Burrell, T
    Gottlieb, AD
    Shen, LZ
    Kolterman, OG
    [J]. DIABETOLOGIA, 2001, 44 : A237 - A237
  • [23] Addition of pramlintide to insulin therapy in type 1 diabetes: Impact on glycemic end weight control stratified by BMI
    Fineman, M
    Maggs, D
    Burrell, T
    Velte, M
    Kolterman, O
    [J]. DIABETES, 2001, 50 : A112 - A112
  • [24] Randomized Comparison of Pramlintide or Mealtime Insulin Added to Basal Insulin Treatment for Patients With Type 2 Diabetes
    Riddle, Matthew
    Pencek, Richard
    Charenkavanich, Supoat
    Lutz, Karen
    Wilhelm, Ken
    Porter, Lisa
    [J]. DIABETES CARE, 2009, 32 (09) : 1577 - 1582
  • [25] Pramlintide, as an adjunct to insulin therapy, led to improved control of both glycemia and weight in African American and Hispanic patients with type 2 diabetes
    Kolterman, O
    Maggs, D
    Burrell, T
    Strobel, S
    Brown, D
    Weyer, C
    [J]. DIABETES, 2003, 52 : A124 - A125
  • [26] Glycemic control and adherence to basal insulin therapy in Taiwanese patients with type 2 diabetes mellitus
    Chien, Ming-Nan
    Chen, Yen-Ling
    Hung, Yi-Jen
    Wang, Shu-Yi
    Lu, Wen-Tsung
    Chen, Chih-Hung
    Lin, Ching-Ling
    Huang, Tze-Pao
    Tsai, Ming-Han
    Tseng, Wei-Kung
    Wu, Ta-Jen
    Ho, Cheng
    Lin, Wen-Yu
    Chen, Bill
    Chuang, Lee-Ming
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (06) : 881 - 888
  • [27] Reduced insulin requirements and improved glycemic control with pioglitazone in insulin-treated patients with type 2 diabetes: Results from PROactive
    Scheen, Andre
    Charbonnel, Bernard
    [J]. DIABETES, 2006, 55 : A134 - A134
  • [28] Improved glycemic control and reduced nocturnal hypoglycemia in patients with type 2 diabetes with morning administration of insulin glargine compared with NPH insulin
    Fritsche, A
    Schweitzer, MA
    Haring, H
    [J]. DIABETES, 2002, 51 : A54 - A54
  • [29] Pramlintide, as an adjunct to premixed insulin, reduced HbA1c and body weight in patients with type 2 diabetes
    Darsow, T.
    Lorenzi, G.
    Zhang, B.
    Maier, H.
    Wilhelm, K.
    [J]. DIABETOLOGIA, 2008, 51 : S409 - S409
  • [30] Adjunctive therapy with pramlintide in insulin-treated patients with type 2 diabetes improved glycemic control and cardiometabolic risk factors in routine clinical practice
    Bhushan, Rajat
    Elkind-Hirsch, Karen E.
    Bhushan, Madhu V.
    Butler, William J.
    Hirsch, David E.
    [J]. DIABETES, 2007, 56 : A557 - A557
12345